Search results for: HCV_TrainerDetails.aspx?id=120

...in learning more about the opioid epidemic and related health issues, Jess jumped at the chance to attend the HCV Current ToT. Before attending, Jess took the online course, HCV...

Integrating hepatitis C (HCV) services into opioid treatment settings can improve access to testing, diagnosis, treatment, and support for individuals with HCV, particularly those with a history of substance use....

...It is based on the Addiction Technology Transfer Center (ATTC) Network’s Your Guide to Integrating HCV Services into Opioid Treatment Programs. HCV services include prevention education, screening,

...products, Guide to Integrating HCV Services into Opioid Treatment Programs, played a key role in helping launch the collaborative. Here's our Q&A with Mehvish Bhatti, project coordinator at the New York...

...healthy living decisions, such as exercising and eating healthy. #NLBHA #NHLATTC #NHLPTTC Resources Office of Minority Health: https://www.minorityhealth.hhs.gov/omh/content.aspx?ID=10238 Men’s Health Network: https://www.menshealthnetwork.or

...on the input. Communicating with Physicians – Sample Form A sample Treatment Coordination Report, developed by Mid-America ATTC, is available for free download, at: http://www.attcnetwork.org/regcenters/productdetails.asp?prodID=

...HCV has been among young people: CDC, Increase in Hepatitis C Infections Linked to Worsening Opioid Crisis Source: CDC  3.  Successful treatments can clear the HCV virus from the body....

DESCRIPTION: This virtual event is the fourth in the series entitled "Intersecting Epidemics in the Context of Ending the Epidemic: Tackling HIV, Substance Use, and HCV". The audience for this program is health care providers and staff working at HIV clinics, infectious disease clinics, substance use disorder treatment programs, opioid treatment programs, and others. By the end of the webinar, participants will be able to: coming soon Trainings with 60 minutes didactic and 60 minutes interactive. Breakout rooms will be part of the interactive piece and will include case study discussion. Program Plan: A 4-hour program: 60-minute didactic presentation on successfully treating active substance users for HCV.  Two additional presenters; one from a substance treatment center and one from an MAT service in a primary care setting to each give an overview of how they have successfully treated HCV in their settings. What they had to do to make it possible to treat their patients.   SPEAKERS: TBD   ACCREDITATION:  Continuing Nursing Education (CNE): The MidAtlantic AIDS Education and Training Center is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association Approver Unit, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Social Work: This program is offered for 2.0 CE hours of social work continuing education through co-sponsorship of the University of Pittsburgh's School of Social Work, a Council on Social Work Education accredited school and therefore a PA pre-approved provider of social work continuing education. These credit hours satisfy requirements for LSW/LCSW, LMFT, and LPC biennial license renewal. More accreditation information coming soon. Continuing Education credits issued for participation in CE activity may not apply toward license renewal in all states. It is the responsibility of each participant to verify the requirements of their state licensing board(s). This virtual conference is provided in collaboration by: The Central East ATTC, MidAtlantic AIDS Education and Training Center (MAAETC), the National Alliance for HIV Education and Workforce Development (NAHEWD), the Opioid Response Network (ORN), and the Mid-Atlantic Regional Public Health Training Center.

  About Hepatitus C Virus (HCV): Over 5 million people in the United States are infected with the hepatitis C virus (HCV). Baby boomers (those born between 1945-1965) and persons with mental health and substance use disorders face an increased risk for infection, yet many are unaware of their

 

  This session is designed for professionals who work with those at risk for contracting Hepatitis C Virus (HCV). An overview of HCV: risk; transmission; symptoms; testing; and treatment options will be provided. In addition, a discussion of harm reduction strategies and support/linkages to care will be included.   At the end of the webinar participants will be able to: Appreciate the importance of Hepatitis C Virus (HCV) screening and confirmatory testing in multiple health and behavioral health settings. Recognize risk factors for HCV Describe harm reduction strategies that minimize the risk of contracting HCV List treatment options available for people with HCV. Discuss strategies to link persons with HCV to HCV-focused health care services  

Event Flyer

In collaboration with the MidAltlantic AIDS Education and Training Center (MAAETC), the CEATTC is hosting an in-person event at the Pittsburgh Marriott North in Cranberry, PA. The topics of discussion include syndemics, advice & best practice communication skills, harm reduction, STI, HCV screening and integration in primary and HIV care, substance use disorder screening & introduction to intervention, mental health screening for suicide & introduction into intervention. Audience Healthcare workers working in the fields of HIV, HCV, STIs, harm reduction, mental health and substance use disorder. Speakers Linda Rose Frank, PhD, MSN, FAAN Ingrid McDowell, MPH Barbara Wilgus, MSN, CRNP Antoine Douaihy, MD Virtual Option The event information on this page is for participants attending the conference in-person on August 30, 2022. Participants have an option to attend virtually if preferred.

This 1.5 hour self-paced course is designed to briefly familiarize federally qualified health center (FQHC) medical and behavioral health staff with Hepatitis C, specifically: 1) populations at risk; 2) Hepatitis C, the disease; 3) screening processes; and 4) treatment options. This course was developed by Mid-America ATTC, part of The Collaborative to Advance Health Services. Revised August 2019.

This presentation described: (1) the epidemics of HIV and HCV among US adolescents and young adults with regional examples. (2) the HIV continuum of care for Adolescents and Young Adults. (3) the value of HIV treatment, and current antiretroviral treatment guidelines and recent updates in care and treatment (4) how to incorporate HIV and HCV prevention, screening and linkage to care into your work with youth. Presented by Cathryn Samples, M.D.

The HCV RNA Provider Card is a small pocket tool to guide medical and behavioral health professionals when discussing HCV RNA test results with patients. The front side provides a visual of the testing algorithm and the back side provides step-by-step instructions for discussing results with patients. The product can be downloaded for free. Hard copies will also be distributed at live training events.

This 90-minute, self-paced course is designed to briefly familiarize medical and behavioral health professionals with hepatitis C virus (HCV), specifically: 1) populations at risk; 2) hepatitis C, the disease; 3) screening processes; and 4) treatment options.

This guide is intended to build the capacity of publicly funded Opioid Treatment Programs (OTPs) to integrate Hepatitis C Virus (HCV) prevention and treatment services into their programs. The guide may also be useful for Federally Qualified Health Centers (FQHCs), community and healthcare coalitions, nonprofit organizations and other substance use disorder and HCV treatment providers. The opioid epidemic has resulted in significant increases in HCV among people who inject drugs, accounting for 23% of new infections. HCV is completely curable and testing and treatment are the path to cure. OTPs play a critical role in comprehensive approaches to addressing HCV and this guide is one tool to help.

This session is designed for professionals who work with those at risk for contracting Hepatitis C Virus (HCV). An overview of HCV: risk; transmission; symptoms; testing; and treatment options will be provided. In addition, a discussion of harm reduction strategies and support/linkages to care will be included.   At the end of the webinar participants will be able to: Appreciate the importance of Hepatitis C Virus (HCV) screening and confirmatory testing in multiple health and behavioral health settings. Recognize risk factors for HCV Describe harm reduction strategies that minimize the risk of contracting HCV List treatment options available for people with HCV. Discuss strategies to link persons with HCV to HCV-focused health care services      

HCV Learning Community Closing Ceremony

This Supplemental Guide is developed as a supplement to Your Guide to Integrating HCV Services into Opioid Treatment Programs. The purpose of these two resources is to build the capacity of publicly funded Opioid Treatment Programs (OTPs) to integrate Hepatitis C Virus (HCV) prevention and treatment services into their programs. The opioid epidemic has resulted in significant increases in HCV among people who inject drugs, accounting for 23% of new infections. HCV is completely curable and testing and treatment are the path to cure. OTPs play a critical role in comprehensive approaches to addressing HCV and this guide is one tool to help.  

Integrating HCV Services into Opioid Treatment Virtual Learning Community Schedule: The first and third Friday of each month between April 12, 2024, and August 9, 2024. Facilitator: Scott Leutgenau, MSW, LCAS, CSI. This nine-session Learning Community is an intensive, collaborative, interactive professional learning opportunity focused on integrating hepatitis C (HCV) services into Opioid Treatment Programs (OTPs) and Office Based Opioid Treatment (OBOTs) in Oklahoma. It is based on the ATTC Network’s Your Guide to Integrating HCV Services into Opioid Treatment Programs. HCV services include prevention, education, screening, antibody HCV tests, confirmatory RNA HCV testing, and HCV treatment, including referrals to outside treatment providers and onsite treatment. Participating providers will learn how to integrate, expand, and enhance HCV services into their current clinical practices. This event is closed. If you are interested in learning more or have questions about joining another cohort, please contact [email protected].